Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Monacolins"'
Publikováno v:
Journal of Future Foods, Vol 3, Iss 4, Pp 312-329 (2023)
Hypercholesterolemia is a risk factor of cardiovascular diseases, which have been managed using statin drugs. Red yeast rice (RYR) as a traditional food in the Eastern Asia countries has anti-hyperlipidemia activity. Recently, a variety of food suppl
Externí odkaz:
https://doaj.org/article/733251aa95284b00840a5380b572b248
Publikováno v:
Avicenna Journal of Phytomedicine, Vol 12, Iss 6, Pp 559-565 (2022)
Objective: Recently, the European Food Safety Authority (EFSA) has recommended to limit the use of total monacolins in red yeast rice (RYR) products to a dose
Externí odkaz:
https://doaj.org/article/c1e4922cc8a541b3b75a714811832f80
Autor:
Feng Yanli, Yu Xiang
Publikováno v:
Frontiers in Microbiology, Vol 11 (2020)
Monacolin K (MK) is a secondary metabolite of the Monascus species that can inhibit cholesterol synthesis. Functional red mold rice (FRMR) is the fermentation product of Monascus spp., which is rich in MK. FRMR is usually employed to regulate serum c
Externí odkaz:
https://doaj.org/article/728fbabedd0b4dda9892177e415d6231
Autor:
Arrigo F.G. Cicero, Federica Fogacci, Martina Rosticci, Angelo Parini, Marina Giovannini, Maddalena Veronesi, Sergio D’Addato, Claudio Borghi
Publikováno v:
Nutrition & Metabolism, Vol 14, Iss 1, Pp 1-7 (2017)
Abstract Background Phytosterols and red yeast rice are largely studied cholesterol-lowering nutraceuticals, respectively inhibiting the bowel absorption and liver synthesis of cholesterol. Our aim was to test the effect on lipid profile of phytoster
Externí odkaz:
https://doaj.org/article/de2f094a4e674c6694a23ff6dabd45c8
Publikováno v:
Molecules, Vol 26, Iss 8, p 2222 (2021)
The use of dietary supplements for the prevention and management of diseases associated with excess of lipids is spreading in Western countries. Supplements containing red yeast rice (RYR) and extracts from Berberis species, characterized, respective
Externí odkaz:
https://doaj.org/article/c491f25cdcbc41ecb83049c058c935dc
Publikováno v:
Therapeutics and Clinical Risk Management, Vol 2016, Iss Issue 1, Pp 281-286 (2016)
Arrigo F G Cicero, Martino Morbini, Angelo Parini, Riccardo Urso, Martina Rosticci, Elisa Grandi, Claudio Borghi Medical and Surgical Sciences Department, University of Bologna, Bologna, Italy Abstract: Our aim was to test, through a crossover, doubl
Externí odkaz:
https://doaj.org/article/9039f4151d7d48b2b456d674c0fd6b3f
Publikováno v:
Nutrients, Vol 12, Iss 10, p 3127 (2020)
Phytosterols and red yeast rice are largely studied cholesterol-lowering nutraceuticals, respectively inhibiting the bowel absorption and liver synthesis of cholesterol. Our aim was to test the effect of combined nutraceutical-containing phytosterols
Externí odkaz:
https://doaj.org/article/31b4fdaa6e3141bd9ad8a2b88cb48db4
Autor:
Rabab Hachem, Gaëtan Assemat, Stéphane Balayssac, Nathalie Martins-Froment, Véronique Gilard, Robert Martino, Myriam Malet-Martino
Publikováno v:
Molecules, Vol 25, Iss 2, p 317 (2020)
Red yeast rice dietary supplements (RYR DS) are largely sold in Western countries for their cholesterol-lowering/regulating effect due to monacolins, mainly monacolin K (MK), which is, in fact, lovastatin, the first statin drug on the market. 1H-NMR
Externí odkaz:
https://doaj.org/article/bf0ef69b705541db85215f01c6b3eacc
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Raffaele Ivan Cincione, Federica Fogacci, Arrigo F G Cicero, Maddalena Veronesi, Marilisa Bove
Publikováno v:
Archives of Medical Sciences. Atherosclerotic Diseases
IntroductionNutraceuticals are a good means to lower cardiovascular risk. Having established a reasonable pharmacological background, a new nutraceutical combination should be tested in clinical trials.Material and methodsThis double-blind, placebo-c